메뉴 건너뛰기




Volumn 22, Issue 2, 2012, Pages 192-196

Tacrolimus 0.1% vs mometasone furoate topical treatment in allergic contact hand eczema: A prospective randomized clinical study

Author keywords

Allergic contact dermatitis; Hand eczema; Mometasone furoate; Tacrolimus

Indexed keywords

CLOBETASOL PROPIONATE; MOMETASONE FUROATE; STEROID; TACROLIMUS;

EID: 84859753542     PISSN: 11671122     EISSN: 19524013     Source Type: Journal    
DOI: 10.1684/ejd.2011.1615     Document Type: Article
Times cited : (35)

References (18)
  • 1
    • 0036823190 scopus 로고    scopus 로고
    • Contact hypersensitivity in hand dermatitis
    • Li L. F, Wang J. Contact hypersensitivity in hand dermatitis. Contact dermatitis 2002; 47: 206-209.
    • (2002) Contact dermatitis , vol.47 , pp. 206-209
    • Li, L.F.1    Wang, J.2
  • 2
    • 34447258147 scopus 로고    scopus 로고
    • North American Contact Dermatitis Group. Contact dermatitis of the hands: Crosssectional analyses of North American Contact Dermatitis Group Data, 1994-2004
    • Warshaw EM, Ahmed RL, Belsito DV, et al. North American Contact Dermatitis Group. Contact dermatitis of the hands: crosssectional analyses of North American Contact Dermatitis Group Data, 1994-2004. J Am Acad Dermatol 2007; 57: 301-314.
    • (2007) J Am Acad Dermatol , vol.57 , pp. 301-314
    • Warshaw, E.M.1    Ahmed, R.L.2    Belsito, D.V.3
  • 4
    • 0026575932 scopus 로고
    • The mechanism of action of cyclosporine A and FK506
    • Schreiber SL, Crabtree GR. The mechanism of action of cyclosporine A and FK506. Immunol Today 1992; 13: 136-142.
    • (1992) Immunol Today , vol.13 , pp. 136-142
    • Schreiber, S.L.1    Crabtree, G.R.2
  • 5
    • 1242269913 scopus 로고    scopus 로고
    • Topical tacrolimus 0.1% ointment (Protopic©) reverses nickel contact dermatitis elucidated by allergen challenge to a similar degree to mometasone furoate 0.1% with greater suppression of late erythema
    • Alomar A, Puig L, Crallardo CM, et al. Topical tacrolimus 0.1% ointment (Protopic©) reverses nickel contact dermatitis elucidated by allergen challenge to a similar degree to mometasone furoate 0.1% with greater suppression of late erythema. Contact Dermatitis 2003; 49: 185-188.
    • (2003) Contact Dermatitis , vol.49 , pp. 185-188
    • Alomar, A.1    Puig, L.2    Crallardo, C.M.3
  • 6
    • 33744993904 scopus 로고    scopus 로고
    • A prospective randomized clinical trial of 0.1% tacrolimus ointment in a model of chronic allergic contact dermatitis
    • Belsito D, Wilson DC, Warshaw E, et al. A prospective randomized clinical trial of 0.1% tacrolimus ointment in a model of chronic allergic contact dermatitis J Am Acad Dermatol 2006; 55: 40-6.
    • (2006) J Am Acad Dermatol , vol.55 , pp. 40-46
    • Belsito, D.1    Wilson, D.C.2    Warshaw, E.3
  • 7
    • 0041856226 scopus 로고    scopus 로고
    • Tacrolimus ointment 0.1% in the treatment of nickel-induced allergic contact dermatitis
    • Saripalli Y, Cradgia E, Belsito D. Tacrolimus ointment 0.1% in the treatment of nickel-induced allergic contact dermatitis. J Am Acad Dermatol 2003; 49: 477-82.
    • (2003) J Am Acad Dermatol , vol.49 , pp. 477-482
    • Saripalli, Y.1    Cradgia, E.2    Belsito, D.3
  • 8
    • 0036149321 scopus 로고    scopus 로고
    • Topical tacrolimus (FK506) and mometasone furoate in treatment of dyshidrotic palmar eczema: A randomized observer-blinded trial
    • Schnopp C, Remling R, Mohsenschlager M, et al. Topical tacrolimus (FK506) and mometasone furoate in treatment of dyshidrotic palmar eczema: a randomized observer-blinded trial. J Am Acad Dermatol 2002; 46: 73-7.
    • (2002) J Am Acad Dermatol , vol.46 , pp. 73-77
    • Schnopp, C.1    Remling, R.2    Mohsenschlager, M.3
  • 9
    • 2342599641 scopus 로고    scopus 로고
    • Tacrolimus ointment in the treatment of eyelid dermatitis
    • Freeman AK, Serle J, VanVeldhuisen P, et al. Tacrolimus ointment in the treatment of eyelid dermatitis. Cutis 2004;73(4):267-71.
    • (2004) Cutis , vol.73 , Issue.4 , pp. 267-271
    • Freeman, A.K.1    Serle, J.2    van Veldhuisen, P.3
  • 10
    • 0035116403 scopus 로고    scopus 로고
    • Human epidermal langerhans cells targets for the immunosupressive macrolide tacrolimus
    • Panhans-Gross A, Novak N, Kraft S, et al. Human epidermal langerhans cells targets for the immunosupressive macrolide tacrolimus. J Allergy Clin Immunol 2001; 107:345-52.
    • (2001) J Allergy Clin Immunol , vol.107 , pp. 345-352
    • Panhans-Gross, A.1    Novak, N.2    Kraft, S.3
  • 11
    • 0037027894 scopus 로고    scopus 로고
    • Effects of FK506(tacrolimus hydrate)in chronic oxazolone induced dermatitis in rats
    • Fujii Y, Takeuchi H, Tanaka K, et al. Effects of FK506(tacrolimus hydrate)in chronic oxazolone induced dermatitis in rats. Eur J Pharmacol 2002;456(1-3):115-21.
    • (2002) Eur J Pharmacol , vol.456 , Issue.1-3 , pp. 115-121
    • Fujii, Y.1    Takeuchi, H.2    Tanaka, K.3
  • 12
    • 62149147507 scopus 로고    scopus 로고
    • Tacrolimus ointment 0.1% in the treatment of allergic contact eyelid dermatitis
    • Katsarou A, Armenaka M, Vosynioti V, et al. Tacrolimus ointment 0.1% in the treatment of allergic contact eyelid dermatitis. J Eur Acad Dermatol Venereol 2009;23(4):382-7.
    • (2009) J Eur Acad Dermatol Venereol , vol.23 , Issue.4 , pp. 382-387
    • Katsarou, A.1    Armenaka, M.2    Vosynioti, V.3
  • 13
    • 0026786760 scopus 로고
    • Inhibition of contact allergy reactions by topical FK506
    • Lauerma AI, Maibach HI, Granlund H, et al. Inhibition of contact allergy reactions by topical FK506. Lancet 1992;340(8818):556.
    • (1992) Lancet , vol.340 , Issue.8818 , pp. 556
    • Lauerma, A.I.1    Maibach, H.I.2    Granlund, H.3
  • 14
    • 0026588246 scopus 로고
    • Immunosupressive macrolides of the type FK506:A novel class of topical agents for treatment of skin diseases
    • Meingassner JG, Stütz A. Immunosupressive macrolides of the type FK506:a novel class of topical agents for treatment of skin diseases. J Invest Dermatol 1992;98(6):851-5.
    • (1992) J Invest Dermatol , vol.98 , Issue.6 , pp. 851-855
    • Meingassner, J.G.1    Stütz, A.2
  • 15
    • 0028063997 scopus 로고
    • Differential inhibition of cutaneous T-cell-mediated reactions and epidermal cell proliferation by cyclosporin A, FK-506, and rapamycin
    • Duncan JI. Differential inhibition of cutaneous T-cell-mediated reactions and epidermal cell proliferation by cyclosporin A, FK-506, and rapamycin. J Invest Dermatol 1994;102(1):84-8.
    • (1994) J Invest Dermatol , vol.102 , Issue.1 , pp. 84-88
    • Duncan, J.I.1
  • 16
    • 27144508387 scopus 로고    scopus 로고
    • Eyeglass frame allergic contact dermatitis: Does tacrolimus prevent recurrences?
    • Nakada T, Iijima M, Maibach HI. Eyeglass frame allergic contact dermatitis: does tacrolimus prevent recurrences? Contact dermatitis 2005;53(4):219-21.
    • (2005) Contact dermatitis , vol.53 , Issue.4 , pp. 219-221
    • Nakada, T.1    Iijima, M.2    Maibach, H.I.3
  • 17
    • 34047217678 scopus 로고    scopus 로고
    • A double-blind randomized placebo-controlled pilot study comparing topical immunomodulating agents and corticosteroids for treatment of experimentally induced nickel contact dermatitis
    • Bhardwaj SS, Jaimes JP, Liu A, et al. A double-blind randomized placebo-controlled pilot study comparing topical immunomodulating agents and corticosteroids for treatment of experimentally induced nickel contact dermatitis. Dermatitis, 2007;18(1): 26-31.
    • (2007) Dermatitis , vol.18 , Issue.1 , pp. 26-31
    • Bhardwaj, S.S.1    Jaimes, J.P.2    Liu, A.3
  • 18
    • 37349125327 scopus 로고    scopus 로고
    • Potential new indications on topical calcineurin inhibitors
    • Epub 2007 Dec 18
    • Luger T, Paul C. Potential new indications on topical calcineurin inhibitors. Dermatology 2007; 215 (Suppl 1):45-54. Epub 2007 Dec 18.
    • (2007) Dermatology , vol.215 , Issue.SUPPL. 1 , pp. 45-54
    • Luger, T.1    Paul, C.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.